- Collagenase
- Trypsin
- Papain
- Elastase
- DNase
- Hyaluronidase
- Other Enzymes
- Non-Enzymatic Dissociation Products
- Instruments
Cell Dissociation Market size was valued at USD 402.6 million in 2022 and is poised to grow at a significant CAGR of 12.5% from 2023-2029. Cell dissociation, also known as trypsinization, is a procedure that uses a proteolytic enzyme to aid in the breakdown of protein to separate adherent cells from the cell culture medium. This breakdown is required so that the cells can be employed again. Cell dissociation reagents can perform proteolytic and collagenolytic actions to detach cell tissues and lines from the glass and plastic surfaces of the container, increasing cell survival and isolation efficiency. The cell dissociation agent chosen is determined by the tissue products or cell type and the age of the cells in the culture medium. Based on the product, the global cell dissociation market is segmented into Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments. The Enzymatic Dissociation Products segment is anticipated to grow at a significant CAGR over the forecast years. The large share of this segment can be attributed increasing incidence of research. Cell dissociation reagents can perform proteolytic and collagenolytic actions to detach cell tissues and lines from the glass and plastic surfaces of the container, increasing cell survival and isolation efficiency. The cell dissociation agent chosen is determined by the tissue or cell type and the age of the cells in the culture medium. The predominance of cell-based research launched by many pharmaceutical and biotechnology businesses is driving the expansion of the cell dissociation industry. Furthermore, the number of pharmaceutical and biotechnology enterprises is growing globally. As a result, this is yet another aspect driving the cell dissociation industry forward.
Cell Dissociation Market Key Developments:
- In 2020, Thermo Fisher Scientific partnered with Symphogen (Denmark) to Extend its strategic collaboration with Symphogen to advance biopharmaceutical discovery and development.
Cell Dissociation Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
12.5%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Cell Dissociation Market Dynamics
The market has expanded due to biopharmaceutical companies investing in research and development. Cell dissociation is critical in biopharmaceutical research since it is directly tied to medicine development and pathophysiology. The biopharmaceutical sector of the pharmaceutical industry is rapidly expanding, with substantial implications for healthcare. Opportunities in the field of biopharmaceuticals have grown in the last ten years because of their high efficacy and safety. The market for biopharmaceutical products has grown due to their advantages, such as their very potent and effective action, typical side effects, and ability to cure diseases rather than only treat their symptoms. The growing emphasis on investment and R&D in the pharmaceutical and healthcare sectors is driving market expansion. The Cell Dissociation Market is predicted to grow due to increased funding from various government agencies and commercial enterprises, the development of improved tissue dissociation enzyme products, and other factors.
Asia-Pacific Got Significant Share
Cell Dissociation Market Regional Analysis
The Cell Dissociation market in North America is likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to rising cancer and other chronic illness incidences, a strong trend of R&D investments in life sciences by industry and academia, and acquisitions and collaboration by the region's leading players are some of the factors driving the market's growth throughout the projection period. For nstance, In 2021, the US was anticipated to witness 1,898,160 new cancer cases and 608,570 cancer-related deaths.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cell Dissociation Market Segmentation
By Product
By Tissue
- Connective Tissues
- Epithelial Tissues
- Others (Skeletal and Muscles Tissues)
By Type
- Tissue Dissociation
- Cell Detachment
By End User
- Pharmaceutical and Biotechnology companies
- Research and Academics
- Others
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
LOCATION
Geography
Frequently Asked Questions
The cell dissociation market size was valued at USD 402.6 million in 2022
The cell dissociation market key players are: VitaCyte, LLC. BD Thermo Fisher Scientific Inc. PAN-Biotech Merck KGaA HiMedia Laboratories Miltenyi Biotec GmbH STEMCELL Technologies Inc. General Electric Company ATCC
The cell dissociation market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Cell Dissociation Market Introduction |
| 2.1.Global Cell Dissociation Market - Taxonomy |
| 2.2.Global Cell Dissociation Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Tissue |
| 2.2.3. Type |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Cell Dissociation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Cell Dissociation Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cell Dissociation Market By Product , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Collagenase |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Trypsin |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Papain |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Elastase |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. DNase |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Hyaluronidase |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Other Enzymes |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Non-Enzymatic Dissociation Products |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Instruments |
| 5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6.Global Cell Dissociation Market By Tissue , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Connective Tissues |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Epithelial Tissues |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others (Skeletal and Muscles Tissues) |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Low Tension Glaucoma |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Cell Dissociation Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Tissue Dissociation |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cell Detachment |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Research Institutes |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Cell Dissociation Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Pharmaceutical and Biotechnology companies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Research and Academics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Cell Dissociation Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Cell Dissociation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Collagenase |
| 10.1.2.Trypsin |
| 10.1.3.Papain |
| 10.1.4.Elastase |
| 10.1.5.DNase |
| 10.1.6.Hyaluronidase |
| 10.1.7.Other Enzymes |
| 10.1.8.Non-Enzymatic Dissociation Products |
| 10.1.9.Instruments |
| 10.2. Tissue Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Connective Tissues |
| 10.2.2.Epithelial Tissues |
| 10.2.3.Others (Skeletal and Muscles Tissues) |
| 10.2.4.Low Tension Glaucoma |
| 10.2.5.Others |
| 10.3. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Tissue Dissociation |
| 10.3.2.Cell Detachment |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Research Institutes |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical and Biotechnology companies |
| 10.4.2.Research and Academics |
| 10.4.3.Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Cell Dissociation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Collagenase |
| 11.1.2.Trypsin |
| 11.1.3.Papain |
| 11.1.4.Elastase |
| 11.1.5.DNase |
| 11.1.6.Hyaluronidase |
| 11.1.7.Other Enzymes |
| 11.1.8.Non-Enzymatic Dissociation Products |
| 11.1.9.Instruments |
| 11.2. Tissue Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Connective Tissues |
| 11.2.2.Epithelial Tissues |
| 11.2.3.Others (Skeletal and Muscles Tissues) |
| 11.2.4.Low Tension Glaucoma |
| 11.2.5.Others |
| 11.3. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Tissue Dissociation |
| 11.3.2.Cell Detachment |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Research Institutes |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical and Biotechnology companies |
| 11.4.2.Research and Academics |
| 11.4.3.Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Cell Dissociation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Collagenase |
| 12.1.2.Trypsin |
| 12.1.3.Papain |
| 12.1.4.Elastase |
| 12.1.5.DNase |
| 12.1.6.Hyaluronidase |
| 12.1.7.Other Enzymes |
| 12.1.8.Non-Enzymatic Dissociation Products |
| 12.1.9.Instruments |
| 12.2. Tissue Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Connective Tissues |
| 12.2.2.Epithelial Tissues |
| 12.2.3.Others (Skeletal and Muscles Tissues) |
| 12.2.4.Low Tension Glaucoma |
| 12.2.5.Others |
| 12.3. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Tissue Dissociation |
| 12.3.2.Cell Detachment |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Research Institutes |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical and Biotechnology companies |
| 12.4.2.Research and Academics |
| 12.4.3.Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Cell Dissociation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Collagenase |
| 13.1.2.Trypsin |
| 13.1.3.Papain |
| 13.1.4.Elastase |
| 13.1.5.DNase |
| 13.1.6.Hyaluronidase |
| 13.1.7.Other Enzymes |
| 13.1.8.Non-Enzymatic Dissociation Products |
| 13.1.9.Instruments |
| 13.2. Tissue Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Connective Tissues |
| 13.2.2.Epithelial Tissues |
| 13.2.3.Others (Skeletal and Muscles Tissues) |
| 13.2.4.Low Tension Glaucoma |
| 13.2.5.Others |
| 13.3. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Tissue Dissociation |
| 13.3.2.Cell Detachment |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Research Institutes |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical and Biotechnology companies |
| 13.4.2.Research and Academics |
| 13.4.3.Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Cell Dissociation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Collagenase |
| 14.1.2.Trypsin |
| 14.1.3.Papain |
| 14.1.4.Elastase |
| 14.1.5.DNase |
| 14.1.6.Hyaluronidase |
| 14.1.7.Other Enzymes |
| 14.1.8.Non-Enzymatic Dissociation Products |
| 14.1.9.Instruments |
| 14.2. Tissue Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Connective Tissues |
| 14.2.2.Epithelial Tissues |
| 14.2.3.Others (Skeletal and Muscles Tissues) |
| 14.2.4.Low Tension Glaucoma |
| 14.2.5.Others |
| 14.3. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Tissue Dissociation |
| 14.3.2.Cell Detachment |
| 14.3.3.Diagnostic Centers |
| 14.3.4.Research Institutes |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical and Biotechnology companies |
| 14.4.2.Research and Academics |
| 14.4.3.Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.VitaCyte, LLC. |
| 15.2.2.BD |
| 15.2.3.Thermo Fisher Scientific Inc. |
| 15.2.4.PAN-Biotech |
| 15.2.5.Merck KGaA |
| 15.2.6.HiMedia Laboratories |
| 15.2.7.Miltenyi Biotec GmbH |
| 15.2.8.STEMCELL Technologies Inc. |
| 15.2.9.General Electric Company |
| 15.2.10.ATCC |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- VitaCyte, LLC.
- BD
- Thermo Fisher Scientific Inc.
- PAN-Biotech
- Merck KGaA
- HiMedia Laboratories
- Miltenyi Biotec GmbH
- STEMCELL Technologies Inc.
- General Electric Company
- ATCC